Andrew Gitkin, head of West Coast biotechnology investment banking at Piper Jaffray, examines first-half performance of critical markets. Also, what impact is Washington’s intransigence having on the markets? And what does this all mean for the healthcare market?
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.